Total Payments
$1,005
2020 Payments
$47.69
Companies
10
Transactions
59
Medicare Patients
1,932
Medicare Billing
$426,336
Payment Breakdown by Category
Food & Beverage$1,005 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,005 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $446.35 | 29 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $177.48 | 9 | $0 (2018) |
| Relypsa, Inc. | $105.18 | 7 | $0 (2019) |
| Amgen Inc. | $62.28 | 2 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $52.15 | 3 | $0 (2019) |
| Allergan Inc. | $49.89 | 3 | $0 (2018) |
| Shire North American Group Inc | $47.76 | 2 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $24.76 | 2 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $20.40 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $18.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $47.69 | 2 | Amgen Inc. ($27.29) |
| 2019 | $359.46 | 23 | OPKO Pharmaceuticals, LLC ($262.12) |
| 2018 | $285.50 | 19 | Keryx Biopharmaceuticals, Inc. ($108.41) |
| 2017 | $312.33 | 15 | OPKO Pharmaceuticals, LLC ($78.00) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Nephrology | ||||||
| 02/20/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: NEPHROLOGY | ||||||
| 11/21/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Hyperparathyroidism | ||||||
| 11/07/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Hyperparathyroidism | ||||||
| 10/21/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Hyperparathyroidism | ||||||
| 10/17/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Hyperkalemia | ||||||
| 09/26/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Hyperparathyroidism | ||||||
| 09/18/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/13/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Hyperparathyroidism | ||||||
| 08/29/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Hyperparathyroidism | ||||||
| 08/29/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Hyperparathyroidism | ||||||
| 08/17/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Hyperparathyroidism | ||||||
| 07/31/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Hyperparathyroidism | ||||||
| 07/02/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Hyperparathyroidism | ||||||
| 06/24/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Hyperparathyroidism | ||||||
| 06/21/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Hyperkalemia | ||||||
| 05/30/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Hyperparathyroidism | ||||||
| 05/15/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Hyperparathyroidism | ||||||
| 05/09/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Hyperparathyroidism | ||||||
| 04/05/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Hyperkalemia | ||||||
| 03/25/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Hyperparathyroidism | ||||||
| 03/16/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Hyperparathyroidism | ||||||
| 03/07/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Hyperparathyroidism | ||||||
| 02/21/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 723 | 1,282 | $353,574 | $147,776 |
| 2020 | 13 | 1,209 | 2,503 | $728,087 | $278,560 |
Total Patients
1,932
Total Services
3,785
Medicare Billing
$426,336
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 46 | 189 | $109,620 | $54,781 | 50.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 285 | 368 | $73,600 | $30,650 | 41.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 137 | 340 | $59,500 | $19,194 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 69 | 78 | $31,200 | $12,500 | 40.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 59 | 135 | $30,375 | $11,300 | 37.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 23 | 34 | $16,354 | $7,789 | 47.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 36 | 65 | $14,300 | $3,831 | 26.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 29 | $8,700 | $3,047 | 35.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 29 | $5,800 | $2,464 | 42.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $4,125 | $2,218 | 53.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 61 | 457 | $265,060 | $106,548 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 332 | 638 | $127,620 | $47,562 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 242 | 590 | $103,250 | $35,099 | 34.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 151 | 164 | $65,600 | $27,317 | 41.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 118 | 231 | $51,975 | $19,638 | 37.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 41 | 77 | $37,037 | $14,797 | 40.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 57 | 70 | $21,000 | $7,871 | 37.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 54 | 117 | $25,740 | $7,116 | 27.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 38 | $10,450 | $4,256 | 40.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 56 | 57 | $5,960 | $2,982 | 50.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $6,000 | $2,347 | 39.1% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2020 | 27 | 27 | $4,995 | $1,530 | 30.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 17 | 17 | $3,400 | $1,497 | 44.0% |
About Dr. Maged Nashed, MD
Dr. Maged Nashed, MD is a Nephrology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083616270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maged Nashed, MD has received a total of $1,005 in payments from pharmaceutical and medical device companies, with $47.69 received in 2020. These payments were reported across 59 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,005).
As a Medicare-enrolled provider, Nashed has provided services to 1,932 Medicare beneficiaries, totaling 3,785 services with total Medicare billing of $426,336. Data is available for 2 years (2020–2021), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Pensacola, FL
- Active Since 06/01/2005
- Last Updated 02/01/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1083616270
Products in Payments
- Rayaldee (Drug) $434.61
- Auryxia (Drug) $177.48
- Veltassa (Drug) $105.18
- ACTHAR (Biological) $52.15
- GATTEX (Drug) $47.76
- Sensipar (Drug) $34.99
- Parsabiv (Drug) $27.29
- SAMSCA (Drug) $24.76
- DALVANCE (Drug) $24.10
- AURYXIA (Drug) $20.40
- LOKELMA (Drug) $18.73
- BYSTOLIC (Drug) $15.26
- Rayaldee (old) (Drug) $11.74
- AVYCAZ (Drug) $10.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Pensacola
Dr. Nicholas Nagrani, M.d, M.D
Nephrology — Payments: $42,955
Nephrology $42,955
Dr. Mark Vannorsdall, M.d, M.D
Nephrology — Payments: $9,629
Nephrology $9,629
Shadi Oweis, Md, MD
Nephrology — Payments: $4,521
Nephrology $4,521
George Antonious, Md, MD
Nephrology — Payments: $4,368
Nephrology $4,368
Linda Stallings, Md, MD
Nephrology — Payments: $3,893
Nephrology $3,893
Dr. Humam Humeda, Md, MD
Nephrology — Payments: $3,094
Nephrology $3,094